Venus Remedies Limited

302.65

INR
+14.05(+4.87%)
As of November 14, 2024 10:00:00 AM

Venus Remedies Limited Share Price Information

24 hour Low and High

Low: 288.3
High: 306

All time High

420.95

Price Change 1h

+₹14.05 +4.87%

Price Change 1d

+₹14.05 +4.87%

Price Change 1w

+₹-14.60 +-4.60%

Venus Remedies Limited Market Information

Exchange

NSE

Market Cap

413.98 Cr

About Venus Remedies Limited Share

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1187

CEO

Mr. Ashutosh Jain B.A., LL.B

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Venus Remedies Limited (NSE:VENUSREM) Held Back By Insufficient Growth Even After Shares Climb 26%
  • Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why
  • Venus Remedies Limited: Shareholders Board Members Managers and Company Profile | INE411B01019
  • Venus Remedies Limited (VRL) recognized for its in-house R&D

FAQs

Venus Remedies Limited

302.65

INR
+14.05(+4.87%)
As of November 14, 2024 10:00:00 AM

Venus Remedies Limited Share Price Information

24 hour Low and High

Low: 288.3
High: 306

All time High

420.95

Price Change 1h

+₹14.05 +4.87%

Price Change 1d

+₹14.05 +4.87%

Price Change 1w

+₹-14.60 +-4.60%

Venus Remedies Limited Market Information

Exchange

NSE

Market Cap

413.98 Cr

About Venus Remedies Limited Share

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1187

CEO

Mr. Ashutosh Jain B.A., LL.B

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Venus Remedies Limited (NSE:VENUSREM) Held Back By Insufficient Growth Even After Shares Climb 26%
  • Shareholders May Not Be So Generous With Venus Remedies Limited's (NSE:VENUSREM) CEO Compensation And Here's Why
  • Venus Remedies Limited: Shareholders Board Members Managers and Company Profile | INE411B01019
  • Venus Remedies Limited (VRL) recognized for its in-house R&D

FAQs